On Stem Cell-Based Therapy
and Male Pattern Alopecia (Opaw)
Male Pattern Alopecia and Stem Cell–Based Therapies
An emerging approach to hair restoration through regenerative medicine
Male pattern alopecia, or androgenetic alopecia (AGA), is the most common cause of hair loss in men. It is characterized by progressive thinning of scalp hair, particularly over the frontal hairline, temples, and crown.
The condition is primarily driven by genetic susceptibility and the effects of dihydrotestosterone (DHT), which gradually miniaturizes susceptible hair follicles, resulting in shorter, finer hairs and, eventually, visible baldness.
Traditional treatments include topical minoxidil and oral finasteride, which can slow hair loss and promote hair growth in appropriate patients.
However, growing interest in regenerative medicine has led to the exploration of platelet-based therapies and cell-based approaches that may improve the scalp microenvironment, support hair follicle activity, and enhance hair density.
Stem cell–based and biologic therapies aim to influence tissue repair and cellular signaling rather than simply replace lost hair.
These approaches may involve growth factors, cytokines, extracellular vesicles, and other biological signals that interact with follicular stem cells and dermal papilla cells.
Their potential applications in hair restoration are promising, although clinical evidence and the degree of benefit vary considerably among treatment modalities.
Which autologous source is best: PRP, PRF, BMAC, or SVF?
For clinical application in male pattern baldness, PRP is currently the most evidence-supported and practical starting option among these four sources.
PRF and SVF are promising alternatives, but there is insufficient high-quality head-to-head evidence to establish that either is superior. BMAC has the least direct clinical evidence for androgenetic alopecia.
PRP — Platelet-Rich Plasma
Concentrates platelets and their growth factors, which may support dermal papilla cell activity, follicular signaling, and hair growth. Clinical trials and systematic reviews have reported improvements in hair density, although study protocols and results
For an orthopaedic and regenerative medicine practice introducing scalp restoration services, I would consider the following approach:
First choice: PRP. It has the more established clinical evidence base, is autologous, and can be administered without harvesting adipose tissue or bone marrow.
Conclusion
PRP is the most defensible first choice today based on clinical evidence, accessibility, and procedural practicality. PRF and SVF merit further investigation, but available studies do not establish a reliable winner among all four sources. BMAC remains insufficiently studied for this indication.
The key objective is not simply to inject cells or growth factors, but to preserve existing follicles, improve hair density and thickness, and achieve measurable, durable outcomes. Standardized preparation, objective hair counts, consistent photographic documentation, and long-term follow-up are essential for evaluating treatment success.
See us today.
ZP